Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The MSD DPhil Day is an annual symposium showcasing the best student work from across the largest division of the University of Oxford. This year was no exception, and on Friday 20th July students from a wide range of scientific backgrounds came together to display their work to a uniquely broad audience.

Thirteen short talks and forty posters were presented and judged by generous volunteer post-docs. Because the overall quality of submissions was very high, it was difficult to pick winners. However, those awarded prizes generally combined rigorous and creative science with excellent communication skills.

In between short talks, a lively panel discussion was chaired by Afsie Sabokbar which focussed largely on the future of scientific publishing, with contributions from past and present editors of Science, The Lancet, and BMJ. We thank our panellists for their impassioned contributions and empathy for students.

The day closed with a keynote speech from Professor Kevin Marsh, senior advisor to the African Academy of Sciences and winner of numerous prizes for his contributions to health in Africa. Professor Marsh used his speech to challenge common misconceptions about the continent. He outlined the rapid socioeconomic change ongoing, and discussed the development of local scientific infrastructure.

The Committee would like to thank all students who attended and especially those who shared their work. Special thanks is also due to Louise Samson, Amanda King, Afsie Sabokbar. 

2018 DPhil day2.jpgBest talks: 1st prize Lisa Simpson (Division of Cardiovascular Medicine, RDM, pictured)

2nd prize Laura Grima (Nuffield Department of Clinical Neurosciences and Experimental Psychology)

Best posters: 1st prize Valentina Gifford (The Kennedy Institute, NDORMS)

2nd prize Rose Hodgson (Centre for Cellular and Molecular Physiology, NDM)

Committee: Caitlin O’Brian Ball, Robert Donat, Deniz Gursul, Ryan Hoyle, Di Hu, Delphine Nzelle Kayem, Peter Liu, Jeff Liu, Jolynne Mokaya, Becky Im, Xanita Saayman, Paolo Spingardi, Sandeep Unwith

 

Similar stories

New form of gift wrap drives male reproductive success

General Research

A study from the Department of Physiology, Anatomy and Genetics (DPAG) has identified a new communication mechanism that ensures the transfer of a complex mix of signals and nutrients required for successful reproduction between males and females.

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Coronavirus COVID-19 General Research

In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.

Early animal studies yield promising results for new potential COVID-19 vaccine

Coronavirus COVID-19 General Research

Studies carried out in the MRC Human Immunology Unit (MRC HIU) in collaboration with the Pirbright Institute have shown that a new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.